NYSE · CAH · Medical Distribution
Cardinal Health, Inc. (CAH) stock analysis
- CAH gained 16.2% over the past month versus 0.0% for the S&P 500, ranking 17th of 497 S&P 500 stocks.
- Over 12 months it returned +64.5%, 48.7 points ahead of the S&P 500, and trades 0.0% below its 52-week high.
- In the last 30 days 1 analyst raised earnings estimates and 1 cut; forward EPS moved −0.1% (+3.6% over 90 days).
- It sits in the Drug distribution segment of the Healthcare Value Chain, where the 1-month median return is +13.9%.
- The daily chart reads Trend transition · Trend repair (since Oct 9, 2026).
One-year price with 50- and 200-day averages
Performance vs the market
Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.
Chart structure
Read by our daily-bar structure engine from swing highs, swing lows and moving averages.
Holding since Oct 9, 2026
- Close above EMA20 above EMA50
- EMA50 rose over the last ten sessions
- Intermediate and long-term directions differ
- Neither a stable trend nor a range is confirmed
42 occurrences in 10 years. The median move over the next 20 sessions was +3.0%, positive 64% of the time, against +1.0% for any day in the same period.
Analyst earnings revisions
Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.
16 analysts cover the stock
Where it sits in the supply chain
Healthcare Value Chain · Distribution & PBMs
Three distributors handle most US prescription drug flow; revenue grows with prescription volume and high-priced specialty drugs, including GLP-1s.
Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps
Risk profile
Track this stock every day
Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.